Effect of an Herbal-Based Injection on 28-Day Mortality in Patients With Sepsis: The EXIT-SEP Randomized Clinical Trial.

Autor:	Liu S; Jiangsu Provincial Key Laboratory of Critical Care Medicine, Department of Critical Care Medicine, Zhongda Hospital, School of Medicine, Southeast University, Nanjing, Jiangsu, China., Yao C; Peking University Clinical Research Institute, Peking University First Hospital, Beijing, China., Xie J; Jiangsu Provincial Key Laboratory of Critical Care Medicine, Department of Critical Care Medicine, Zhongda Hospital, School of Medicine, Southeast University, Nanjing, Jiangsu, China., Liu H; Department of Critical Care Medicine, The First Hospital of Shanxi Medical University, Taiyuan, Shanxi, China., Wang H; Department of Critical Care Medicine, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, China., Lin Z; Department of Emergency and Critical Care, Shanghai Changzheng Hospital, Shanghai, China., Qin B; Department of Critical Care Medicine, Henan Provincial People's Hospital, Zhengzhou, Henan, China., Wang D; Department of Critical Care Medicine, The Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou, China., Lu W; Department of Critical Care Medicine, Yijishan Hospital, The First Affiliated Hospital of Wannan Medical College, Wuhu, Anhui, China., Ma X; Department of Critical Care Medicine, The First Affiliated Hospital, China Medical University, Shenyang, Liaoning, China., Liu Y; Key Laboratory of Chinese Internal Medicine of Ministry of Education and Beijing, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, China., Liu L; Jiangsu Provincial Key Laboratory of Critical Care Medicine, Department of Critical Care Medicine, Zhongda Hospital, School of Medicine, Southeast University, Nanjing, Jiangsu, China., Zhang C; Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, China., Xu L; Department of Critical Care Medicine, Tianjin Third Central Hospital, Tianjin, China., Zheng R; Department of Critical Care Medicine, Northern Jiangsu People's Hospital, Yangzhou, Jiangsu, China., Zhou F; Department of Critical Care Medicine, Chinese PLA General Hospital, Beijing, China., Liu Z; Department of Critical Care Medicine, The First Hospital of Jilin University, Changchun, Jilin, China., Zhang G; Department of Emergency, China-Japan Friendship Hospital, Beijing, China., Zhou L; Department of Critical Care Medicine, First People's Hospital of Foshan, Foshan, Guangdong, China., Liu J; Department of Critical Care Medicine, The First Hospital of Lanzhou University, Lanzhou, Gansu, China., Fei A; Department of Emergency, Xinhua Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, China., Zhang G; Department of Emergency, The First Affiliated Hospital of Henan Science and Technology University, Luoyang, Henan, China., Zhu Y; Hunan Provincial Institute of Emergency Medicine, Hunan Provincial People's Hospital, Changsha, Hunan, China., Qian K; Department of Critical Care Medicine, The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China., Wang R; Department of Emergency, Shanghai General Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, China., Liang Y; Department of Critical Care Medicine, Yantai Yuhuangding Hospital of Qingdao University, Yantai, Shandong, China., Duan M; Department of Critical Care Medicine, Beijing Friendship Hospital, Capital Medical University, Beijing, China., Wu D; Department of Critical Care Medicine, Qilu Hospital of Shandong University (Qingdao), Qingdao, Shandong, China., Sun R; Department of Critical Care Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China., Wang Y; Department of Respiration, Chinese PLA General Hospital of Rocket Forces, Beijing, China., Zhang X; Department of Anesthesiology, Xijing Hospital, Xi'an, Shaanxi, China., Cao Q; Department of Critical Care Medicine, Jiangsu Province Hospital, Nanjing, Jiangsu, China., Yang M; Department of Critical Care Medicine, The Third Xiangya Hospital of Central South University, Changsha, Hunan, China., Jin M; Department of Critical Care Medicine, Yanbian University Hospital, Yanji, Jilin, China., Song Y; Department of Critical Care Medicine, Central Hospital of Shenyang Medical College, Shenyang, Liaoning, China., Huang L; Department of Critical Care Medicine, Yantaishan Hospital, Yantai, Shandong, China., Zhou F; Department of Critical Care Medicine, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China., Chen D; Department of Critical Care Medicine, Ruijin North Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, China., Liang Q; Department of Critical Care Medicine, First Affiliated Hospital, Heilongjiang University of Chinese Medicine, Harbin, Heilongjiang, China., Qian C; Department of Emergency, First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, China., Tang Z; Department of Emergency, Chinese PLA Wuhan General Hospital, Wuhan, Hubei, China., Zhang Z; Department of Critical Care Medicine, Shenzhen Traditional Chinese Medicine Hospital, Shenzhen, Guangdong, China., Feng Q; Department of Emergency, Shanghai Sixth People's Hospital, Shanghai, China., Peng Z; Department of Critical Care Medicine, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, China., Sun R; Department of Critical Care Medicine, Zhejiang Provincial People's Hospital, Hangzhou, Zhejiang, China., Song Z; Department of Emergency, Zhongshan Hospital, Fudan University, Shanghai, China., Sun Y; Department of Critical Care Medicine, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China., Chai Y; Department of Emergency, Tianjin Medical University General Hospital, Tianjin, China., Zhou L; Department of Critical Care Medicine, The Affiliated Hospital of Inner Mongolia Medical University, Hohhot, Inner Mongolia, China., Cheng C; State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Zhangjiang Hi-Tech Park, Shanghai, China., Li L; First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, National Clinical Research Center for Chinese Medicine Acupuncture and Moxibustion, Tianjin, China., Yan X; Peking University Clinical Research Institute, Peking University First Hospital, Beijing, China., Zhang J; Evidence-Based Medicine Center, Tianjin University of Traditional Chinese Medicine, Tianjin, China., Huang Y; Jiangsu Provincial Key Laboratory of Critical Care Medicine, Department of Critical Care Medicine, Zhongda Hospital, School of Medicine, Southeast University, Nanjing, Jiangsu, China., Guo F; Jiangsu Provincial Key Laboratory of Critical Care Medicine, Department of Critical Care Medicine, Zhongda Hospital, School of Medicine, Southeast University, Nanjing, Jiangsu, China., Li C; State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Zhangjiang Hi-Tech Park, Shanghai, China., Yang Y; Jiangsu Provincial Key Laboratory of Critical Care Medicine, Department of Critical Care Medicine, Zhongda Hospital, School of Medicine, Southeast University, Nanjing, Jiangsu, China., Shang H; Key Laboratory of Chinese Internal Medicine of Ministry of Education and Beijing, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, China., Qiu H; Jiangsu Provincial Key Laboratory of Critical Care Medicine, Department of Critical Care Medicine, Zhongda Hospital, School of Medicine, Southeast University, Nanjing, Jiangsu, China.
Jazyk:	angličtina
Zdroj:	JAMA internal medicine [JAMA Intern Med] 2023 Jul 01; Vol. 183 (7), pp. 647-655.
DOI:	10.1001/jamainternmed.2023.0780
Abstrakt:	Importance: Previous research has suggested that Xuebijing injection (XBJ), an herbal-based intravenous preparation, may reduce mortality among patients with sepsis. Objective: To determine the effect of XBJ vs placebo on 28-day mortality among patients with sepsis. Design, Setting, and Participants: The Efficacy of Xuebijing Injection in Patients With Sepsis (EXIT-SEP) trial was a multicenter, randomized double-blind, placebo-controlled trial conducted in intensive care units at 45 sites and included 1817 randomized patients with sepsis (sepsis 3.0) present for less than 48 hours. Patients aged 18 to 75 years with a Sequential Organ Failure Assessment score of 2 to 13 were enrolled. The study was conducted from October 2017 to June 2019. The final date of follow-up was July 26, 2019. Data analysis was performed from January 2020 to August 2022. Interventions: The patients were randomized to receive either intravenous infusion of XBJ (100 mL, n = 911) or volume-matched saline placebo (n = 906) every 12 hours for 5 days. Main Outcomes and Measures: The primary outcome was 28-day mortality. Results: Among the 1817 patients who were randomized (mean [SD] age, 56.5 [13.5] years; 1199 [66.0%] men), 1760 (96.9%) completed the trial. In these patients, the 28-day mortality rate was significantly different between the placebo group and the XBJ group (230 of 882 patients [26.1%] vs 165 of 878 patients [18.8%], respectively; P < .001). The absolute risk difference was 7.3 (95% CI, 3.4-11.2) percentage points. The incidence of adverse events was 222 of 878 patients (25.3%) in the placebo group and 200 of 872 patients (22.9%) in the XBJ group. Conclusions and Relevance: In this randomized clinical trial among patients with sepsis, the administration of XBJ reduced 28-day mortality compared with placebo. Trial Registration: ClinicalTrials.gov Identifier: NCT03238742.
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu